Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MONITORING SYSTEMS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources

Development of a radiology report monitoring system for case tracking.

OBJECTIVE: The objective was to develop an automated system to monitor and collect radiology reports for case-tracking purposes. CONCLUSION: The system we developed allows users to automate the case-tracking process for either clinical follow-up or teaching purposes. With this system, radiologists can initiate the tracking of a case by dictating a keyword into the report. Any existing and future reports associated with the same patient will be collected automatically. The schematic that we developed is based on the Health Level Seven (HL7) standard, which is platform-independent. In our implementation, we used an IBM-compatible computer and commercially available software. Users can monitor the case-tracking progress from Web browsers.

Humans↗

European Concerted Action on Anticoagulation (ECAA): an assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT.

Previously, the attempt to simplify the International Sensitivity Index (ISI) calibration of the CoaguChek Mini whole blood point-of-care test prothrombin time (PT) monitor system was successful using lyophilized plasmas from coumarin-treated patients but not with lyophilized artificially depleted plasmas. With the TAS PT-NC monitor system, both types of plasma failed to provide reliable calibrations. The present study assesses a procedure for the ISI calibration of a TAS PT-NC and CoaguChek Mini whole blood point-of-care test PT monitor systems using lyophilized plasmas. Using lyophilized artificially depleted and coumarin plasma calibrations, we have evaluated a correction for the monitor displayed PT. This was based on a 'line of equivalence' derived from the relationship between whole blood and fresh plasma PT with both types of monitor system. With the TAS PT-NC, the use of this 'line of equivalence' resulted in reliable ISI with both lyophilized coumarin and artificially depleted plasmas. There was no significant difference between mean monitor and mean reference International Normalized Ratio (INR) with the artificially depleted plasmas. With the lyophilized coumarin plasma calibrations there was only a small INR difference. Correction with the 'line of equivalence' therefore facilitates calibration of the TAS PT-NC with lyophilized plasmas. With the CoaguChek Mini, the correction based on the 'line of equivalence' did not improve results but was not required with this system.

Blood Preservation↗

Equivalence of fast flush and square wave testing of blood pressure monitoring systems.

BACKGROUND: The accurate recording of intraarterial pressure depends upon an appropriate dynamic response of the monitoring system. Generation of a square wave (SW) at the catheter tip is the engineering and in vitro laboratory gold standard. Fast flush (FF) testing is the clinical test of choice. Results from these two test methods have been assumed equal but have not been empirically confirmed. METHODS: We studied three different 5.1 cm catheter sizes (16 G, 18 G, 20 G Becton Dickinson, Sandy, UT) attached to three different lengths of arterial pressure tubing (36 in, 91.4 cm; 72 in, 182.9 cm; 108 in, 274.3 cm). An arterial recording system was assembled in the standard fashion by attaching a catheter to arterial pressure tubing, which was attached to a transducer (TXX-R, Ohmeda, formerly Viggo-Spectramed, Oxnard, CA) whose signal was recorded by a strip chart recorder (Gould 2400, Rolling Meadows, IL). The system was attached to a pressurized saline flush. The catheter tip was inserted into one port of a pressure generator. With the other port of the pressure generator open to atmosphere, FF tests were performed by activating the flush device of the transducer. Subsequent step response signals from the FF tests were then recorded from which natural frequency (fn) and damping coefficient (zeta) were calculated. Next, square waves were generated by closing the port that was open to atmosphere and attaching a signal generator to a pressure generator. Square waves so generated were recorded as described above and natural frequency and damping coefficients calculated. These procedures were repeated after 0.05 cc of air was introduced in the transducer and repeated again in a system containing a damping device (R.O.S.E., Resonant OverShoot Eliminator, Viggo-Spectramed, Oxnard, CA). RESULTS: There was no significant difference between fn and zeta as calculated from the step response generated from the FF test versus fn and zeta as calculated from the square wave (SW) test in systems without air. However, in systems containing air, fn by FF testing was always less than fn by SW testing for all catheter sizes and extension tubing lengths (p < 0.05). Damping was also always greater by FF testing than by SW testing in systems with air for all catheter sizes and extension tubing lengths (p < 0.05). The R.O.S.E device created marked qualitative differences, although exact fn and zeta could not be quantified. CONCLUSIONS: For the characterization of dynamic response of invasive blood pressure monitoring systems, the FF test and SW test yield identical results. However, under certain conditions-air, R.O.S.E device-dynamic response as measured by FF testing was not equivalent to dynamic response as measured by the gold standard-the SW test. Specifically, small amounts of air in fluid-filled invasive blood pressure monitoring systems cause a slightly worse dynamic response as measured by FF testing versus the laboratory gold standard-the SW test.

Blood Pressure Monitors↗

Pilot-testing a statewide outcome monitoring system: overview of the California Treatment Outcome Project (CALTOP).

Timely information provided by an effective outcome monitoring system (OMS) is key to making improvements in treatment program effectiveness, service provision, and client outcomes. The California Treatment Outcome Project (CalTOP) developed and pilot-tested an automated outcome monitoring system for California's alcohol and other drug (AOD) system of care. CalTOP was designed to track client movement through treatment programs, measure standardized assessment of client service needs, record service utilization, assess treatment outcomes and client satisfaction, and determine the extent to which treatment produces cost-offsets in other health and social service systems. Information collected by CalTOP revealed that client problem severity at admission was high, services needed were diverse, and treatment services were generally not well matched to the level of problem severity or needs of clients. Also, client retention and length of stay in treatment were generally insufficient to maximize the potential benefits associated with treatment. This article presents the type of information on client demographics and treatment retention that was provided by CalTOP and outlines recommendations for implementing an AOD outcome monitoring system statewide.

Adult↗

Neural monitoring system for circulating somatostatin in the hepatoportal area.

If a peptide hormone secreted from the gastroenteropancreatic (GEP) system is monitored by the hepatic vagal nerve, the nerve can signal the central nervous system and thereby exert control on its target organs. In this review, we offer a line of evidence for the hypothesis. When a physiological dose of somatostatin (SS), one of the GEP hormones, was injected into the rat portal vein, the spike discharge rate in the hepatic afferent vagus increased significantly. This SS-induced activation of the vagus was completely abolished by a prior administration of our monoclonal antibody to SS receptor into the portal vein. We further disclosed a morphological basis for this neural reception to SS in the hepatoportal area: the neural bodies, located beneath the endothelium of the rat portal vein, preferentially bound the exogenous SS injected intraportally as revealed immunohistologically. The bodies contained a structure of the nerve fiber arborizations resembling those of the afferent apparatus of Krause, on which the presence of SS receptor was confirmed histochemically using the anti-SS receptor antibody. These results provide a new insight into the receptor-mediated neural reception to GEP hormones in the hepatoportal area, implying the potential role of the reception in the GEP physiology.

Animals↗

First results from an intensified monitoring system to estimate drug related hospital admissions.

AIMS: An intensified monitoring system was set up to identify drug related hospital admissions and estimate population-based incidences for commonly prescribed medications. METHODS: Pharmacovigilance-centres systematically screened nonelective admissions to emergency rooms or departments of internal medicine for drug related hospitalizations (DRH). Clinical pharmacologists used standardized causality assessment. Service areas of each acute care hospital were defined by 5 digit postal codes that covered 60% of all admissions. Drug dispensing information was available through claims processed by regional pharmacy computing centres. Quarterly incidences were estimated by dividing the number of events by the number of treated patients. RESULTS: 435 DRHs were reported during five quarters. The incidence of ADRs leading to admissions varied for specific drug groups from 1.5/10 000 treated patients to 24/10 000. Quarterly variation of incidences was moderate except for insulin and calcium antagonists. 95% confidence intervals overlap for all quarters within each group. Incidences are sensitive to changes in the definition of the source population. CONCLUSIONS: Our pharmacovigilance monitoring system allows comparisons of population-based incidences of drug-related hospitalizations among drugs and over time. It provides important information for risk management and monitoring outcomes of pharmaceutical quality management programmes.

Adverse Drug Reaction Reporting Systems↗

Development of remote control and monitoring system for the FE gun in HVEM.

This paper describes a control and monitoring system for the field emission (FE) gun in the high-voltage electron microscope (HVEM), where the whole FE gun system is located inside a pressure vessel and is floated on a high voltage of 1 MV. The operating condition of the FE gun system is controlled and monitored mainly by a bi-directional communication system between ground and high potential through optical fibres. A mechanical driving system by combination of insulator rods and stepping motors is partially used as a control system for FE gun operation. The monitoring system developed here also functions as a safety circuit that detects abnormal situations, such as an abnormal deterioration of vacuum, and protects the FE tip against fatal damage. The fundamental performance of the microscope has been tested for transmission electron microscope (TEM) and scanning TEM operation modes.

Journal Article↗

Developing a state outcomes monitoring system in public health maternal and child health.

State outcomes monitoring systems are increasingly important as state governments develop outcomes-based accountability in response to recent federal legislation. A state outcomes monitoring system developed for state and local maternal and child public health departments allows for outcomes research as well as administration and management.

Case Management↗

Design and development of a monitoring system to assess the quality of hospital information systems: concept and structure.

Hospital information systems (HIS) are a substantial quality and cost factor in health care. Systematic monitoring of HIS quality is an important task for information management; however, this task is often seen to be insufficiently supported by available methods and tools. The aim of this research project is to develop a comprehensive monitoring system to assess the quality of hospital information systems, taking into account both computer-based and paper-based information processing.The structure of the developed monitoring system consists of a matrix, crossing HIS quality criteria on one axis (e.g., accessibility of information, or correctness and completeness of information) with a list of process steps within patient care on the other axis (e.g., patient admission, order entry, or clinical documentation). Relevant fields in this matrix, being defined by one quality criterion and one process step, contain detailed questions, that access the HIS quality with regard to the given criterion in a given process step.Based on the matrix, a questionnaire with around 140 questions has been developed, consisting of specific questions for physicians, nurses and other professional groups. The ongoing international evaluation will verify completeness, reliability, validity, and feasibility of this HIS quality monitoring system. First evaluation steps point to a high acceptance of this approach among IT staff and clinical staff.

Computers↗

Patient monitoring systems: criteria for evaluation & selection.

Patient monitoring is more than just the acquisition and accumulation of physiological data. In order for it to be efficacious in patient diagnosis and treatment, the professional staff must be continuously involved in protocol development, evaluation, and modification. Given the constraints of these tasks, of cost limitations, and of staff interest and expertise, the clinical engineer should develop a rationale for making judgments about patient monitoring systems at his particular site. This rationale should include: evaluation of design criteria from medical, nursing, and engineering standpoints; consideration of the considerable and increasing effect of computers on monitoring; and the intelligent appraisal of technique and system development performed at other sites.

Bibliographies as Topic↗

Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method. Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients.

OBJECTIVE: To develop a reliable and practical glucose monitoring system by combining a needle-type glucose sensor with a microdialysis sampling technique for long-term subcutaneous tissue glucose measurements. RESEARCH DESIGN AND METHODS: A microdialysis Cuprophan hollow-fiber probe (inner diameter, 0.20 mm; length, 15 mm) was perfused with isotonic saline solution (120 microliters/h) and glucose concentrations in the dialysate were measured by a needle-type glucose sensor extracorporeally. This system was tested both in vitro and in vivo. Subcutaneous tissue glucose concentrations were then monitored continuously in 5 healthy and 8 diabetic volunteers for 7 to 8 days. A hollow-fiber probe was inserted into the abdominal subcutaneous tissue. RESULTS: This monitoring system achieved excellent results in vitro. Subcutaneous tissue glucose concentrations were measured in a wide range from 1.7 to > 27.8 mM glucose, with a time delay of 6.9 +/- 1.2 min associated with a rise in glucose and 8.8 +/- 1.6 min with a fall in the glucose level (means +/- SE). The overall correlation between subcutaneous tissue (Y) and blood (X) glucose concentration was Y = 1.08X + 0.19 (r = 0.99). The subcutaneous tissue glucose concentration could be monitored precisely for 4 days without any in vivo calibrations and for 7 days by introducing in vivo calibrations. CONCLUSIONS: Glycemic excursions could be monitored precisely in the subcutaneous tissue by this microdialysis sampling method with a needle-type glucose sensor in ambulatory diabetic patients.

Adult↗

Direct measurement of hepatic tissue hypoxia by using a novel tcpO2/pCO2 monitoring system in comparison with near-infrared spectroscopy.

BACKGROUND/AIMS: Hepatic hypoxia occurs during liver surgery and transplantation and it may also appear within liver tumours, correlating with prognosis and efficacy of the treatment. The present study measured liver tissue hypoxia by directly using near-infrared spectroscopy (NIRS) and a novel tcpO2/pCO2 monitoring system. METHODS: Graded hypoxia was achieved in a rabbit model by a stepwise reduction of the fraction of inspired oxygen (FiO2) from 0.3 to 0.0. Animals were allowed to recover from hypoxia at FiO2 of 3.0 indicated by normalised arterial blood gas values. Hepatic tissue oxyhaemoglobin (HbO2), deoxyhaemoglobin (Hb), cytochrome oxidase (Cyt Ox), oxygen partial pressure (pO2) and carbon dioxide partial pressure (pCO2) were measured continuously with the help of NIRS and a Clark-type surface tcpO2/pCO2 monitoring system, throughout the period of hypoxaemia. RESULTS: There was an immediate reduction in hepatic HbO2 with hypoxia and a simultaneous increase in hepatic Hb. Similarly, hepatic tissue pO2 decreased significantly but tissue pCO2 remained unchanged until the FiO2 was below 0.1. Hepatic HbO2 showed a positive correlation with tissue pO2 (r = 0.53, P < 0.001). Hepatic Hb showed a negative correlation with tissue pO2 (r = 0.47, P < 0.001). Hepatic Cyt Ox decreased significantly with an FiO2 of 0.1 or less and showed a positive correlation with hepatic tissue pO2 (r = 0.64, P < 0.001). A significant correlation was found between hepatic tissue pO2 and arterial blood pO2 (r = 0.44, P < 0.001). Arterial blood pCO2 also correlated with hepatic tissue pCO2 (r = 0.53, P < 0.001) measured by the tcpO2/pCO2 monitoring system. CONCLUSION: The data from the present study suggest that, like NIRS, the tcpO2/pCO2 monitoring system can be reliably used for the direct monitoring of hepatic tissue oxygenation in vivo.

Animals↗

Ventilation/perfusion indices do not correlate with the difference between oxygen consumption measured by the Fick principle and metabolic monitoring systems in critically ill patients.

OBJECTIVE: To determine whether the difference between oxygen consumption (VO2) measured by metabolic gas monitoring systems and by the Fick principle is related to venous admixture, deadspace/tidal volume ratio, or alveolar-arterial oxygen tension gradient in critically ill patients. DESIGN: A prospective study. SETTING: An 11-bed general ICU in a 900-bed teaching hospital. PATIENTS: Twenty critically ill patients admitted to the ICU who required mechanical ventilation, right heart catheterization, and arterial and mixed venous gas measurements for normal clinical management. RESULTS: Thirty-three recordings were analyzed. The mean VO2 measured by the metabolic gas monitoring system was 308 +/- 63.9 (SD) mL/min and was significantly greater than the mean VO2 measured by the Fick principle of 284 +/- 72.0 mL/min. The difference between the two measurements of 24.3 +/- 47.6 mL/min correlated poorly with venous admixture (r2 = .0009), dead-space/tidal volume ratio (r2 = .0064) and alveolar-arterial oxygen tension gradient (r2 = .017). CONCLUSIONS: If the difference in VO2 measured by metabolic gas monitoring systems and the Fick principle is due to intrapulmonary VO2 then in critically ill patients the ventilation/perfusion indices of venous admixture, deadspace/tidal volume ratio and alveolar-arterial oxygen tension gradient correlate poorly with intrapulmonary VO2.

Adult↗

Nightcap: a home-based sleep monitoring system.

In an attempt to offer a home-based adjunct to traditional sleep laboratory methods, we developed a system to monitor sleep, and to predict algorithmically non-rapid-eye-movement (NREM) and rapid-eye-movement (REM) sleep states, using eye and body motility as the only parameters. Eye movement was measured using a strain gauge transducer applied to the eyelid of subjects, while body movement was measured using a piezo-ceramic phono cartridge. Both transducers were mounted on a tennis headband, along with electronics that amplified, filtered, and digitized the signals. Digital pulse signals were input to a portable computer in minute-long epochs, and state-predicting algorithms were run based on this motility data. Four subjects were monitored in the sleep lab with both our headgear and standard polysomnography. Hand-scored sleep records were compared with those predicted by computer algorithms. Algorithm-predicted states agreed with hand-scored ones an average of 85.57% (SEM +/- 1.7%). Mean values for sleep onset and REM latency were within 1.6 and 10.8 min of polysomnographic records, respectively. These results are encouraging, and suggest that this system could provide a comfortable, subject operable, and inexpensive method for the evaluation of sleep at home.

Adult↗

[Development of a wireless multiple physiological parameters monitoring system].

This paper presents a scheme of a wireless multiple physiological parameters monitoring system, and gives a detail description on the hardware and software realization. This system utilizes wireless communication technology, embedded micro internet working technology and medical service technology in the remote monitoring system.

Equipment Design↗

[Hygienic assessment of trace element levels in drinking water and food products within the system of socio-hygienic monitoring system].

The paper provides a comprehensive hygienic assessment of the levels of the essential and toxic trace elements chosen in terms of regional features in drinking water and foodstuffs of locally manufactured products. Priority pollutants of drinking water and foodstuffs are defined in the eastern, western, and central lands of the Orenburg Region. A significant imbalance of essential trace elements was revealed. Daily oral intake of priority and toxic trace elements were calculated in foodstuffs and drinking water.

Catchment Area, Health↗

[Portable home monitoring system in screening for sleep-disordered breathing].

Screening for sleep-disordered breathing is often done in an interview and with a questionnaire. This method is indirect and it appears to underestimate the prevalence of sleep apnea syndrome. Recently, several devices such as the Medilog and Vitalog portable monitoring systems were developed. However, these devices are difficult for patients to operate by themselves, because they include EEG monitoring or measurement of chest and abdominal movement. Therefore, we developed a portable monitoring system that is easier to operate. This system can be used to assess three variables: oronasal airflow, tracheal sound, and electrical activity of the heart. It stores the time of the onset of apnea, apnea duration, and R-R intervals with a built-in microcomputer. Apnea episodes, total apnea time, mean apnea time, and R-R interval are analyzed with a host computer. The sensitivity an specificity of this system are 92.5% and 87.5%, respectively, with an apnea index (AI) of less than 10 episodes/h. Using this device, we found that the prevalence of sleep apnea syndrome among Japanese industrial workers who had an AI of more than 10 episodes was 7.5%. Moreover, from 1984 to 1994 we used this device to monitor 1019 outpatients who complained of sleep disturbances such as snoring, abnormal breathing during sleep, and excessive daytime sleepiness, and found sleep apnea (AI > or = 10) in about 50% of these patients. This monitoring system is useful for screening of outpatients with sleep apnea and for epidemiological studies of sleep apnea. However, it may be necessary to include a non-invasive system for monitoring oxygen saturation in the portable sleep monitor, to detect hypoventilation during sleep.

Adolescent↗

In vivo monitoring system for structure-function relationship analysis of the antibacterial peptide apidaecin.

A unique antibacterial peptide derivative found in immune honeybee lymph, apidaecin 1b (AP1), was randomly mutagenized and characterized by a newly established system to analyze in vivo its structure-function relationship. Initially, a high-level expression host-vector system for AP1 in Escherichia coli was constructed by creating a fusion protein with the highly stable Streptomyces subtilisin inhibitor (SSI) molecule. Expression of the SSI-AP1 fusion protein was found to depend on the concentration of the transcriptional inducer isopropyl-beta-D-thio-galactopyranoside (IPTG) and to parallel the degree of growth inhibition of the transformant cells. Subsequently, apidaecin derivatives produced by localized random mutagenesis were screened with this IPTG concentration-controlled in vivo system by monitoring the growth inhibition patterns of the transformant cells. One mutant apidaecin (P9L) that had reduced activity was purified and isolated from the periplasmic fraction of an E. coli transformant. Its antibacterial activity was reduced to one-third of that of wild-type apidaecin. When considered together with the other mutations, it was concluded that several Pro residues, including that at the ninth position, are responsible for expression of the antibacterial action of apidaecin.

Amino Acid Sequence↗